Arcutis Biotherapeutics Inc.
ARQT | NASDAQ
$27.41
+$1.45 (+5.59%)
Sep 22, 2026, 11:54 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -223.38 | -12.01 | -0.85 | -2.61 | -4.97 | -7.40 |
PEG Ratio | 2.52 | 0.17 | 0.03 | -0.07 | -0.51 | -0.03 |
PS Ratio | 9.82 | 8.57 | 3.76 | 220.96 | n/a | n/a |
PB Ratio | 19.50 | 10.70 | 2.52 | 3.89 | 3.44 | 3.71 |
P/FCF Ratio | -585.47 | -15 | -0.90 | -2.90 | -5.83 | -8.85 |
P/OCF Ratio | -656.87 | -15.02 | -0.91 | -3.16 | -5.87 | -8.88 |
OCF/S Ratio | -1.50 | -57.07 | -414.48 | -6.99K | n/a | n/a |
Debt / Equity Ratio | 0.03 | 0.70 | 2.32 | 0.97 | 0.26 | 0.02 |
Quick Ratio | 2.99 | 3.97 | 6.80 | 11.37 | 12.09 | 12.96 |
Current Ratio | 3.17 | 4.15 | 7.08 | 11.57 | 12.09 | 12.96 |
Asset Turnover | 0.87 | 0.56 | 0.17 | 0.01 | n/a | n/a |
Interest Coverage | -1.01 | -4.73 | -8.11 | -19.27 | n/a | n/a |
Return on Equity | -8.52% | -88.89% | -295.65% | -148.61% | -69.32% | -50.14% |
Return on Assets | -3.73% | -40.14% | -76.79% | -69.32% | -50.56% | -45.49% |
Return on Invested Capital | -4.02% | -47.79% | -81.61% | -73.07% | -55.04% | -49.57% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 90.24% | 90.27% | 91.63% | 79.54% | n/a | n/a |
Net Profit Margin | -4.29% | -71.25% | -439.79% | -8.45K% | n/a | n/a |
Pretax Profit Margin | -3.98% | -70.92% | -434.57% | -8.45K% | n/a | n/a |
Operating Profit Margin | -3.25% | -65.33% | -404.49% | -8.18K% | n/a | n/a |
FCF Margin | -1.68% | -57.14% | -415.20% | -7.62K% | n/a | n/a |
EBITDA Margin | 0.66% | -55.78% | -381.56% | -7.99K% | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove ARQT